Bioavailability Study of Valganciclovir Hydrochloride Tablets 450 mg Under Fed Condition

Phase 1 Completed 66 enrolled Dr. Reddy's Laboratories Limited

RandomizedCrossoverOpen-labelTreatment

Summary

This study is to assess the Valganciclovir Hydrochloride Tablets 450 mg of Dr. Reddy's Laboratories Limited, India and Valcyte® (Valganciclovir HCl) tablets 450 mg of Genentech USA Inc., Group of Roche, South San Francisco in healthy, adult, human subjects under Fed conditions.

Timeline

Start: 2011-07
Primary completion: 2011-07
Completion: 2011-08

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Valganciclovir	Small molecule	450 mg	Oral

Indications

No indication recorded.